Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates

Cancer Research - United States
doi 10.1158/0008-5472.can-10-4322
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Activity of EGFR, mTOR and PI3K Inhibitors in an Isogenic Breast Cell Line Model

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2014English

Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Pro-Apoptotic Activity of Ruxolitinib Alone and in Combination With Hydroxyurea, Busulphan, and PI3K/mTOR Inhibitors in JAK2-Positive Human Cell Lines

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Antitumor Activity of MEK and PI3K Inhibitors Against Malignant Pleural Mesothelioma Cells in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2012English

Design, Synthesis and Biological Evaluation of Novel Phenylsulfonylurea Derivatives as PI3K/mTOR Dual Inhibitors

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Antioxidant, Metabolic and Antitumor Activity of Triterpenoids Combination With Cytostatics

International Journal of Pharmacy and Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy